I’ve been confused about Steve Jobs cancer and the course of his illness by reading the lay press, and decided to look into what’s up in light of his resignation as CEO from Apple this week. It took very little research to find out the situation and why his course of what has been labeled “pancreatic cancer” but has not taken the typical course of pancreatic cancer. That is because the cancer Jobs has is not the typical pancreatic cancer. Steve Jobs announced in 2004 at a press release that he was diagnosed with a neuroendocrine tumor of the islet cells of the pancreas. Although this is a cancer originates in the pancreas it is not at all like the typical pancreatic adenocarcinoma. The typical cancer of the pancreas has an abysmal prognosis. The 5-year survival rate with pancreatic cancer is very poor, estimated at 16% when localized to the pancreas and less than 7% for other patients. Only about 7% or patients are in the former category, so overall the prognosis for survival is extremely poor.
Pancreatic neuroendocrine tumors are a completely different cancer. They originate in the cells of the pancreas that produce insulin, the islet cells, and are often called islet cell tumors. This cancer is in a family of cancers called neuroendocrine tumors that sometimes are found in families with hereditary predisposition to this type of tumors called MEN 1. (MEN stands for multiple endocrine neoplasia)
Mr. Jobs announced in a company e-mail in 2004 that he had undergone a successful surgery for an islet cell pancreatic tumor. He underwent an extensive surgery to remove the pancreas and surrounding tissues called a Whipple procedure. This is a very big surgery for some time he seemed to do well. Over the last couple of years it appears that his health has been in decline, and this week he announced his resignation as CEO of Apple.
Pancreatic islet cell cancer is a rare type of cancer. There are about 2500 cases of this cancer diagnosed in the U.S. annually. IN many cases of pancreatic islet cell cancer surgery can be curative, and aggressive surgery is often undertaken as was the case in Steve Jobs cancer. These tumors can be either benign or malignant. In Steve Jobs cancer it was malignant. The islet cells produce several hormones, including insulin, gastrin and others. When the tumors are functioning to make one of these hormones the symptoms can be very dramatic. Insulinomas, tumors that produce insulin, can produce severe and refractory hypoglycemia. Tumors that produce gastrin, the pancreatic hormone that leads to gastric acid secretion in the stomach, gastric and duodenal ulcers that are recurrent and refractory to treatment can occur. This is sometimes called Zollinger-Ellison syndrome. Measurement of serum insulin levels or serum gastrin levels can help in the diagnosis of these tumors.
I bought my first Macintosh computer in 1988 and love my iPhone today. Although I use a PC for most of my day-to-day work, I do love Apple products, and it has been fun to see the ups and downs of Apple and Steve Jobs over the years. Mr. Jobs has been a controversial, colorful and undeniably brilliant force behind Apple computer, and it is sad to see him leave the company at a relatively young age because of health concerns. I hope his prognosis is better than it appears and will certainly add him to my prayer list.



